AvKARE is recalling 341 cartons of Irbesartan (Irbesartan Tablets USP), 300 mg, a medication used to treat high blood pressure. This recall affects the 50-tablet unit dose cartons because the tablets failed testing for dissolution, which means they may not break down and release the medicine correctly once swallowed. If you have been taking this medication, you should consult with your healthcare provider or pharmacist regarding your treatment.
If the tablets do not dissolve properly in the digestive tract, the body may not absorb enough of the active medicine. This can lead to poorly controlled blood pressure and an increased risk of health complications related to hypertension.
You have 2 options:
341 cartons affected
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.